East African Collaborations in Practical Synthetic Biology Workshop
- Posted on 13 March
From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking place in Nairobi, Kenya. This will bring together researchers and policymakers from East Africa with academics and entrepreneurs from Imperial College London, University of Cambridge, University of Edinburgh and the John Innes Centre. The workshop will explore potential E. African application areas for practical synthetic biology including disease detection, agri-technology, environment, industrial processes as well as policy, IP and commercialisation opportunities.
The key objectives of this workshop are:
- Develop programmes on synthetic biology research and training
- Identify practical applications for synthetic biology solutions and biotechnologies
- Establish networks and collaborations on synthetic biology between Eastern African & UK researchers
- Facilitate communication, information exchange and education on synthetic biology
This is a unique and important opportunity for collaboration and we look forward to updating you on the insights to be generated from this meeting.
Share this article:
People also read
Breathing chandeliers and algae sculptures: bionic art comes to the V&A
Arborea, based in Imperial College’s White City innovation hub, has been featured in the Financial Times.
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology, Metrology and Standards
NPL, the UK's National Measurement Institute (NMI), and SynbiCITE at Imperial College London, have announced the establishment of a new £7 million virtual lab to underpin their joint Centre for Engineering Biology, Metrology and Standards to help the UK synthetic biology industry improve the manufacturing and adoption of new products - in partnership with LGC and NIBSC.
£17 million boost to the UK’s leading life sciences sector
The Chancellor of the Exchequer, Philip Hammond, announced this week £17million new funding will be supplied for UK life science, helping to create real benefits for the NHS and patients.